Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis

AUTOR(ES)

Trídico, Lívia Arroyo, Antonio, João Roberto, Mathias, Carlos Eduardo, Pozetti, Eurides Maria de Oliveira

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2017-10

RESUMO

Documentos Relacionados

• Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
• Psoriatic Arthritis: A Comparative Radiographic Study of Rheumatoid Arthritis and Arthritis Associated with Psoriasis
• HLA antigens in psoriasis and psoriatic arthritis.
• Cervical Spine in Psoriasis and in Psoriatic Arthritis *
• Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.